Natera, Inc.(NTRA) - Stock detail

Natera, Inc.

US
NTRA
Natera, Inc.(Listing date: 07/02/2015)

Natera, Inc. was incorporated in Delaware in January 2007. The company is a diagnostic company with proprietary molecular and bioinformatics technologies that it is applying to transform disease management worldwide. The company's cell-free DNA (cfDNA) technology combines novel molecular analytical methods that can reliably measure many informative regions across the entire genome from samples as small as a single cell, as well as statistical algorithms that incorporate data provided by the broader scientific community to identify genetic variations covering a wide range of serious diseases with high precision and high coverage. The company's goal is to make personalized genetic testing and diagnosis part of the standard of care for protecting health and inform earlier and more targeted interventions to help achieve longer, healthier lives.

AI Technical AnalystHold
Rating4/10
Generated at:2026-04-24 17:41:36
Analysis based on real-time data as of 2026-04-24. Data analysis range from 2025-12-29 to 2026-04-24 (117 calendar days, 42 trading days). Requested range was 60 trading days. Data source: US Stock Market real-time data for Natera, Inc. (NTRA).
Insight

NTRA is in a consolidation phase within a broader downtrend, showing high volatility and no clear directional bias, with a neutral to cautious outlook.

Resistance
256.36
Support
167.99
Support and resistance are estimated from the latest 60 sessions.
Strategy
  • Short-term:For short-term trading (1-2 weeks), expect continued range-bound trading between $200 and $210. Watch for a breakout above $210.14 with volume expansion for a bullish signal, or a breakdown below $198/$184 for a bearish signal. The high volatility (ATR ~$10) increases risk, so position sizing should be conservative.
  • Mid-term:For medium-term investment (1-3 months), maintain a neutral stance. Consider entry only on a confirmed bullish breakout above the $205.50-$210.14 resistance cluster with strong volume, targeting resistance near $218. A more conservative approach would be to wait for a firm hold of the $184-$200 support zone before considering a long position.
  • Long-term:For long-term investment (3+ months), the primary trend from the January high is still down. Monitor whether the current consolidation resolves into a new trend direction. A sustained close above $210.14 could signal a trend reversal attempt, while a break below $184 would confirm continued downtrend. Broader market conditions and company-specific news will be critical drivers.

Moving averages

MA 5
205.17
MA 20
202.79
MA 60
210.14
Price
203.75
AI Analysis
  • The moving average structure shows a short-term bearish alignment but with potential for stabilization.
  • The 5-day SMA at $205.17 and the 10-day SMA at $205.41 are both above the current close of $203.75, indicating recent price weakness.
  • The 20-day SMA at $202.79 is providing immediate support just below the current price.
  • The 60-day SMA at $210.14 is significantly above all shorter-term averages, acting as a major resistance level.
  • The stock is confirmed to be in a medium-term downtrend from higher levels.
  • The Exponential Moving Averages (EMAs) tell a similar story, with the EMA_20 at $205.54 also above the current price, reinforcing resistance.

Volume

Volume
1.00M
20D Avg
1.28M
Institution
-
Participation
-
AI Analysis
  • Volume has been highly variable, which is typical for consolidation.
  • A massive volume spike on 2026-04-10 (2.87 million shares, the highest in the dataset) coincided with a sharp drop to $193.03.
  • This suggests a potential capitulation event or a major transfer of shares, often seen near short-term bottoms.
  • Subsequent volume has remained elevated compared to earlier periods, indicating continued high interest and uncertainty.
  • The most recent volume of 1,000,365 shares is above the early-year average, confirming active participation at current levels.

MACD

MACD
-1.54
Signal
-2.02
Hist
0.48
Trend
-
AI Analysis
  • The MACD line is at -1.5292 and the signal line is at -2.0057.
  • The MACD histogram (MACDH) is positive at 0.4765.
  • This configuration suggests that while the stock remains in a bearish zone (negative MACD), the momentum of the downtrend is decelerating, as the histogram has turned positive.
  • This is a potential early sign of weakening selling pressure, but not yet a confirmed bullish crossover.

Bollinger bands

Upper
218.67
Middle
202.79
Lower
186.91
Width
15.66%
AI Analysis
  • The bands are calculated with a 20-day SMA ($202.79) as the middle band.
  • The upper band is at $218.67 and the lower band at $186.91.
  • The current price of $203.75 is trading just above the middle band, indicating the short-term trend is neutral to slightly positive within the context of the band.
  • The width of the bands (Upper - Lower = $31.76) suggests a moderate level of volatility.
  • The price is far from the upper band resistance and closer to the middle band support.

RSI

RSI(14)
48.39
RSI(6)
48.39
Overbought
70+
Oversold
30-
AI Analysis
  • The Relative Strength Index (RSI_6) stands at 48.39.
  • This places the indicator in neutral territory, slightly below the midpoint of 50.
  • It indicates a balance between buying and selling forces with a slight edge to sellers.
  • There is no overbought (>70) or oversold (<30) condition, suggesting the stock is not at an extreme and has room to move in either direction.

KDJ

K
48.60
D
54.92
J
35.96
Trend
-
AI Analysis
  • The K value (48.60) is below the D value (54.92), and the J line is at 35.96.
  • This indicates a bearish crossover in the short-term stochastic oscillator, suggesting downward momentum may be resuming after a brief pause.

Chip distribution

How chip distribution helps you?
Chip distribution summary
  • The estimated chip distribution shows a high profit ratio of 73.48% with a concentrated cost base between $149.99 and $216.80, suggesting potential support near the lower end of this range.
  • The provided chip distribution is an estimate based on historical price and turnover behavior.
  • It uses a volume-based proxy for turnover rate to model where trading activity (and thus potential cost bases for holders) has been concentrated over a 60-day window.
  • The data shows a high profit ratio of 73.48%, meaning most recent trading activity occurred above the estimated average cost of $171.97.
  • The 70% cost concentration range is between $149.99 and $216.80, with a tight concentration value of 18.21%.
  • This suggests a relatively concentrated cost base within this range.
  • The current price (~$204) sits in the upper-middle part of this 70% concentration band.
  • This implies there is a significant amount of (chips) held at a profit below the current price.
  • If the price falls towards the lower end of this band (near $150), it could encounter strong support from holders seeking to defend their paper profits or break-even points.
  • Conversely, overhead resistance is suggested by the 90% range upper bound of $236.14.
No chart data

Data is estimated based on turnover rate, high, low, open, and close prices. Profit ratios may vary significantly across different brokerage tools.